T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2B |
| 2 |
Sea Limited
SE
|
+$1.34B |
| 3 |
Morgan Stanley
MS
|
+$1.23B |
| 4 |
Incyte
INCY
|
+$1.05B |
| 5 |
Ross Stores
ROST
|
+$968M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.05B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.5B |
| 3 |
Visa
V
|
+$1.16B |
| 4 |
JPMorgan Chase
JPM
|
+$1.13B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.44% |
| 2 | Healthcare | 17.77% |
| 3 | Consumer Discretionary | 14.38% |
| 4 | Financials | 11.9% |
| 5 | Communication Services | 10.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Employers Holdings
EIG
$872M
| $25.5M | ﹤0.01% |
846,038
+340
| +0% | +$10.5K |
|
1077
International Flavors & Fragrances
IFF
$21.3B
| $25.4M | ﹤0.01% |
207,484
-14,749
| -7% | -$1.86M |
|
1078
Masco
MAS
$14.7B
| $25.3M | ﹤0.01% |
504,116
-76,939
| -13% | -$3.34M |
|
1079
W.W. Grainger
GWW
$62.1B
| $25.3M | ﹤0.01% |
80,557
-7,021
| -8% | -$2.03M |
|
1080
Hercules Capital
HTGC
$3.14B
| $25.2M | ﹤0.01% |
2,409,554
+46,965
| +2% | +$477K |
|
1081
Option Care Health
OPCH
$3.61B
| $25.2M | ﹤0.01% |
1,813,816
-31,116
| -2% | -$411K |
|
1082
Hilton Grand Vacations
HGV
$3.55B
| $25.1M | ﹤0.01% |
1,284,065
-23,389
| -2% | -$461K |
|
|
GRMN
1083
Garmin
GRMN
$60.2B
| $25M | ﹤0.01% |
256,444
-19,318
| -7% | -$1.65M |
|
1084
James River Group Holdings
JRVR
$196M
| $24.9M | ﹤0.01% |
553,335
+5,423
| +1% | +$202K |
|
1085
Guidewire Software
GWRE
$14.6B
| $24.8M | ﹤0.01% |
224,093
-15,262
| -6% | -$1.47M |
|
|
AGFS
1086
DELISTED
AgroFresh Solutions Inc
AGFS
| $24.8M | ﹤0.01% |
8,197,495
-106,422
| -1% | -$264K |
|
|
MCF
1087
DELISTED
Contango Oil & Gas Co.
MCF
| $24.8M | ﹤0.01% |
10,834,111
+831,721
| +8% | +$2.03M |
|
1088
JELD-WEN Holding
JELD
$165M
| $24.7M | ﹤0.01% |
1,533,968
+159,444
| +12% | +$2.1M |
|
|
ITCI
1089
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $24.7M | ﹤0.01% |
961,749
-532,736
| -36% | -$10.8M |
|
1090
John B. Sanfilippo & Son
JBSS
$1.01B
| $24.7M | ﹤0.01% |
288,962
-2,594
| -0.9% | -$220K |
|
1091
A.O. Smith
AOS
$8.48B
| $24.4M | ﹤0.01% |
517,656
-77,155
| -13% | -$3.37M |
|
1092
FMC
FMC
$1.29B
| $24.3M | ﹤0.01% |
243,983
-19,410
| -7% | -$1.79M |
|
1093
Hewlett Packard
HPE
$78.3B
| $24.2M | ﹤0.01% |
2,490,033
-225,776
| -8% | -$2.22M |
|
1094
Arcturus Therapeutics
ARCT
$232M
| $24.2M | ﹤0.01% |
+517,837
| New | +$17.8M |
|
|
AAT
1095
American Assets Trust
AAT
$1.41B
| $24.2M | ﹤0.01% |
868,600
+5,001
| +0.6% | +$137K |
|
1096
TherapeuticsMD
TXMD
$24M
| $24M | ﹤0.01% |
383,438
-3,773
| -1% | -$220K |
|
1097
DaVita
DVA
$11.6B
| $23.9M | ﹤0.01% |
301,832
-15,050
| -5% | -$1.18M |
|
1098
First Bancorp
FBNC
$2.76B
| $23.9M | ﹤0.01% |
952,426
-11,172
| -1% | -$269K |
|
1099
Qorvo
QRVO
$8.55B
| $23.8M | ﹤0.01% |
215,628
-22,212
| -9% | -$2.2M |
|
1100
KeyCorp
KEY
$24.9B
| $23.7M | ﹤0.01% |
1,943,207
-120,540
| -6% | -$1.4M |
|
Similar funds
T. Rowe Price Associates's Q2 2020 Portfolio in Review
As of Q2 2020, T. Rowe Price Associates held 2,591 positions worth $795B, up 26% from $632B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
T. Rowe Price Associates's Q2 2020 filing shows 79 new, 1,096 increased, 1,255 reduced and 100 closed positions. Its largest new stake was Vroom Inc: 200,362 shares worth $797M. The largest sale was Boeing, an estimated $2.05B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2020 buy was Vroom Inc: 200,362 shares worth $797M.
- T. Rowe Price Associates added most to Microsoft in Q2 2020, an estimated $2B increase.
- T. Rowe Price Associates's biggest Q2 2020 reduction was Boeing, cutting an estimated $2.05B.
- T. Rowe Price Associates fully exited Raytheon Company in Q2 2020, selling an estimated $1.01B.
- T. Rowe Price Associates's ten largest holdings make up 25% of its $795B portfolio in Q2 2020.
- T. Rowe Price Associates opened 79 new positions and closed 100 in Q2 2020.
- T. Rowe Price Associates's portfolio value rose 26% quarter-over-quarter to $795B.
Based on T. Rowe Price Associates's 13F filing for Q2 2020, filed 14 Aug 2020.